Item 8.01. Other Events.
On April 1, 2009, a three-member arbitration panel from the International Centre for Dispute Resolution issued an interim award (the "Interim Award") rejecting all claims asserted by Digene Corporation (now Qiagen Gaithersburg, Inc.) ("Digene") in the arbitration proceeding brought by Digene against Gen-Probe Incorporated (the "Company") and the Company's co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc. (together, "Roche"). The arbitration proceeding concerns the Company's supply and purchase agreement with Roche for human papillomavirus (HPV) products. The Interim Award remains subject to further proceedings related to its implementation, including requests by the Company and Roche for reimbursement of attorney's fees and related expenses.
A copy of the Company's news release announcing the issuance of the Interim Award is attached as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 News Release of Gen-Probe Incorporated dated April 1, 2009.

---